Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)

Market Cap	36.05B -11.7%
Revenue (ttm)	77.66B +3.6%
Net Income	2.98B +5.2%
EPS	1.84 +5.2%
Shares Out	1.63B
PE Ratio	12.68
Forward PE	12.12
Dividend	0.90 (3.88%)
Ex-Dividend Date	n/a

Volume	2,223,210
Average Volume	12,433,803
Open	23.24
Previous Close	23.27
Day's Range	23.17 - 23.26
52-Week Range	23.00 - 27.85
Beta	0.29
RSI	22.33
Earnings Date	Mar 20, 2026

About SHA:600332

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials. The company operates through Great Southern TCM, Great Commerce, Great Health, and Other segments. It is also involved in the wholesale, retail, sale, import, and export of Western and Chinese medicines, medical instruments, pharmaceutical products, medical apparatus, and healthcare products; research...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1997
• Employees: 27,425
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600332

Financial Performance

In 2025, SHA:600332's revenue was 77.66 billion, an increase of 3.55% compared to the previous year's 74.99 billion. Earnings were 2.98 billion, an increase of 5.21%.